Phibro Animal Health | PAHC - Operating Expenses

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $332.36M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Align Technology USD 822.85M 11.8M Dec/2025
ANI Pharmaceuticals USD 505.82M 309.62M Sep/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 146.03M 27.79M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Canopy Growth CAD 80.99M 8.64M Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Henry Schein USD 3.14B 77M Sep/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Merck USD 10.16B 558M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Pacira USD 166.36M 4.5M Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 200.95M 6.51M Dec/2025
Supernus Pharmaceuticals USD 252.29M 98.98M Sep/2025
Zoetis USD 1.55B 3.85B Dec/2025